ARTICLE | Company News
Corixa, Gen-Probe deal
January 10, 2005 8:00 AM UTC
CRXA granted GPRO rights to IP covering genetic sequences for about 50 markers of prostate, ovarian, cervical, kidney, lung and colon cancers. GPRO will use the markers, which include AMACR for prost...